A Cold Chamber Cannot Rescue a Bad Diet: Dr Claire-Marie Roberts and the Ailment of Football's Sports Science

Rome in summer, 36 degrees, and before lunch my inbox already holds four pitches: a sleep tracker, a magnetic mattress, ionised water, and a "cellular regeneration" device whose mechanism I still cannot explain. None of the senders know I am a journalist. They only see an address in Italy and a keyword in a bio.

The story that made me stop longest came from someone else. Dr Claire-Marie Roberts recalls a man calling her club and opening with a rhetorical question: "Did you know the atmosphere is only 21 percent oxygen?" From that premise he derived a solution: compressed oxygen cans. She declined. What matters is that he called at all, and that he believed he would sell them.

She receives roughly 50 pitches like that every week on LinkedIn. Fifty. Every week. Not every transfer window, not every month.

I have been in this trade since 2026, covering eight Olympic Games and eight World Cups, and I have learned one simple thing: when sellers outnumber buyers, buyers stop inspecting the goods. Professional football sits in exactly that condition, except the goods are wrapped in scientific language.

Context: a doctor standing between two worlds

Claire-Marie Roberts was born in 2026, was a swimmer, and missed the 2026 Olympics through injury. She spent nine years working inside the Premier League environment, two years at Coventry City, and now serves as Director of Human Performance at McLaren in Formula 1. During her Coventry period she worked with Frank Lampard's coaching staff and — by her own account — applied an evidence-based method. I flag that passage as a detail requiring independent verification, because the original piece offers no concrete data from that period.

Her interview was conducted by The Guardian and later republished by VnExpress. It is an opinion interview, not a data report. No tables, no expected goals, no financial figures, no release clauses. Precisely because it lacks tables, it is worth reading: warnings without charts are usually warnings issued from inside the engine room, where people see equipment failing before sponsors see the invoice.

The conversation circles a category anyone following professional football encounters daily: cold chambers, ice baths, supplements, kinesiology tape. All are widespread at elite clubs. Most carry no clear evidence.

I am writing this during a transfer window, and I am deliberately placing it beside the deals currently in motion. The same money can go in two directions: to a 24-year-old centre-back, or to a cold chamber. Both get called "investment in performance". A sheet of paper from 2026 still sits in my drawer – I never erase the history of my mistakes. On it I marked a question that remains unanswered: which club verified that what it bought actually works?

Cold chambers everywhere, and nobody can explain why

Roberts says something that stopped me: most top clubs have cold chambers, but when she asks why they use them, the answers tend to be vague. Nobody articulates a specific physiological mechanism. Nobody points to the study that convinced them. They have a cold chamber because another club has a cold chamber.

This is the kind of error I call expensive inventory: it does not sit in the safe, it sits in the training ground, and it never appears on the balance sheet.

The more striking detail is technical. Roberts notes that recent studies suggest cold therapy may reduce muscle adaptability. In training-ground language: if the goal after a match is to create a stimulus for muscle growth, shutting down the inflammatory response immediately may erase part of that stimulus. Cold chambers are not proven harmless for physical development, and in some cases they may work against the very objective the club is pursuing.

I have no independent data to confirm or refute this. But I have enough professional experience to recognise a behavioural pattern: when an expensive product cannot demonstrate efficacy, people switch to defending it with the reputation of whoever bought it first. Reputation needs no evidence.

Ice baths, and a photograph heavier than a scientific paper

Roberts mentions the image of Harry Kane in an ice bath after a Bayern Munich match at the FIFA Club World Cup. One photograph. A few hundred thousand likes. Within days it becomes part of the shared language of recovery.

Based on my experience watching matches in Serie A, I see this clearly from the stands: images travel faster than data, and images with a star travel faster than everything. A 19-year-old academy player who sees that photo will not go looking for a systematic review of cold therapy. He will go buy ice.

An ice bath is not dangerous. It is cheap, easy, and to some degree genuinely soothing. The problem is the order of priorities: when a player spends twenty minutes in ice but sleeps five and a half hours a night, the club has invested in the wrong place.

Kinesiology tape and three names that cannot be argued with

Cristiano Ronaldo, Gareth Bale, David Beckham. Three names associated with kinesiology tape for years. Roberts says evidence that tape prevents injury or improves performance is very limited.

I will not argue with a player's subjective sensation. If a player feels more confident with a strip of tape on his thigh, and that confidence helps him play better, the effect is real. But that effect does not require any particular product. It requires belief, and belief can be manufactured far more cheaply.

The problem lies elsewhere. Those three names can never be rebutted by saying "the research does not support it." Fans do not read research. They see Ronaldo. To them, Ronaldo is the evidence.

Supplements: a billion-dollar industry and the principle of strict liability

Roberts cites a macro figure: the supplement industry is a billion-dollar market, and it has reached into football. She argues that supplementation should rest on genuine need, and that many players use products without truly understanding what they are taking.

This is the part of the interview with the heaviest consequences, and also the least noticed, because it produces no attractive imagery.

Strict liability in anti-doping means the athlete is responsible for everything in their body, including a substance that contaminated a product they bought with entirely innocent intent. That turns every capsule into a legal risk rather than a nutritional one.

In such a system, a club's failure to batch-test supplements is a hidden liability, and that liability can be called in at any moment — usually at the most expensive possible moment.

I have sat through enough meetings in Serie A to know that when a player receives a doping sanction, the damage is not shared equally. The player loses a career. The club loses points, reputation, transfer value. And the people who sold the product lose nothing at all.

Sleep and nutrition: two free therapies nobody wants to hear about

Roberts places sleep and nutrition above everything. She argues that no cold chamber compensates for a bad diet, and no supplement carries a lopsided nutrition plan.

This sounds so simple it feels trivial, which is exactly why it gets ignored. Sleep has no distributor. Nutrition has no sales representative. Nobody earns a commission when a player sleeps eight hours.

I went back through some old notes of mine on Serie A deals in recent years and found a familiar pattern: the clubs spending most on recovery devices tend to be the clubs with the densest fixture lists and the tightest wage bills. They buy equipment to solve a problem whose real location is elsewhere — in their reluctance to rotate, because the squad is too thin for the calendar.

The halo effect: when a club buys because Chelsea bought

Roberts names England, Manchester City and Chelsea as trend-setters. When a successful club adopts a method, other clubs assume the method works. Belief forms not through research but through the league table.

This mechanism has an exact name in psychology: illusory correlation. In football, it has real financial consequences.

Manchester City and Chelsea can fund experiments without touching core operations. A mid-table Serie A club cannot. When a mid-table club copies a big club, it does not copy the supporting apparatus — not the sports science staff, not the control procedures, not the capacity to absorb financial error.

It copies the equipment.

The transmission chain, and Brescia in March 2026

Draw the line and it runs like this: manufacturers and research upstream; clubs, players and performance staff in the middle; media, commerce and player health downstream. Pressure flows downward, and evidence flows back up very slowly.

I saw that current in its rawest form in March 2026, when a Brescia club employee called me and said one short sentence: "Please help us." An empty stadium. Three months of unpaid wages. Insolvency on the meeting table.

I convened a nine-hour online meeting between the board, the captain and representatives of the Italian Players' Association. The outcome was a wage agreement split into four instalments. The club avoided bankruptcy. Twenty-seven player families could breathe.

I saw a player cry in a meeting room over three months of unpaid wages – football is not only tactics. And I have never forgotten this detail: in that same month, an agent sent the club a pitch for a new recovery device, stamped with the line "a strategic investment in the future".

The club owed wages. Someone was still selling equipment.

The clock remains the biggest variable

Before we talk transfers, we talk time – one wrong clock kills an entire deal.

I repeat this because it explains the pull of pseudoscience in football. A coach with three days between matches cannot buy an extra week of rest. He cannot extend the season. He cannot negotiate with the fixture list. The only thing he can buy is the feeling of having done something useful.

Pseudoscience sells exactly what professional football lacks most: a way to shorten recovery time. In an environment where three days is all you have, the promise of "faster recovery" carries more weight than any evidence.

In 2026, midway through the World Cup in Russia, I received a call from Ivan Perišić's agent. Inter Milan wanted to trigger a 50 million euro release clause, but the contract carried an expiry point of 15 July. We identified the bottleneck as timing, extended the clause to 31 July, and the deal closed at 45 million euros plus 5 million in variables.

No cold chamber saved that transfer. A correct calendar did.

The contrarian angle: the blind spot of the warning itself

I have to say this before finishing, otherwise I will commit precisely the error I am criticising.

The interview cites no specific research. "Recent studies" are invoked without authors, journals, sample sizes or confidence intervals. This is an expert interview resting on personal authority, and personal authority — however formidable — is not data. I note this because I learned that lesson in 2026, when a fake account spread the claim that Gonzalo Higuaín wanted to leave Juventus on 7 million euros a season, drawing 2.1 million views in five hours. I spent six hours verifying the contract with Lega Serie A. My correction drew 30,000 reads. The false story kept running. Since then I assert nothing without two independent sources, even when the speaker is a leading expert.

The "pseudoscience" label may also be too broad. Cold therapy may work in specific contexts — immediate pain relief, helping a player feel better after a match. Dismissing an entire field on the basis of one interview is a weak scientific move.

But here is the largest blind spot, and I say it as someone who files paperwork rather than reads dashboards: the most expensive pseudoscience in football is not a cold chamber. A cold chamber costs tens of thousands of euros. A "potential" assessment used to justify the salary of a 20-year-old costs tens of millions. An "individual development pathway" drawn up to convince a president that a transfer fee is reasonable — that is pseudoscience at industrial scale.

Both forms serve the same purpose: converting an emotional decision into one that looks evidence-based.

What I am waiting for

Clubs that build evidence-based performance departments will gain a quiet advantage, and that advantage will not appear in the news feed. It will appear in April, when their squad is intact and their opponent's is not.

I am waiting for two specific things. First, batch testing of supplements becoming a clause in player contracts, like a release clause or an extension option. Second, a club publishing why it bought a recovery device, with references attached.

If the second does not happen within two years, I will have my answer to the question I wrote down in 2026. And the answer will simply be this: football still buys on faith, and only the invoice is written in real numbers.